Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    SAB Biotherapeutics Inc.

    NASDAQ: SABS · Real-Time Price · USD
    1.79
    0.09 (5.29%)
    At close: Jun 17, 2025, 1:04 PM

    SAB Biotherapeutics Revenue

    SAB Biotherapeutics reported an annual revenue of $1.32M, reflecting a -40.94% growth. For the quarter ending March 31, 2025, SAB Biotherapeutics generated $0 in revenue.
    Revenue (ttm)
    $1.32M
    Revenue Growth
    -40.94%
    Price / Sales Ratio
    26.54
    Revenue / Employee
    $20.98K
    Employees
    63
    Market Cap
    16.62M

    Revenue Chart

    Revenue History

    Fiscal Year End Revenue % Change
    Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

    Add to Watchlist